Medical Affairs Advisor Haematology Oncology

Req #: 1900975
Location: Hillingdon, United Kingdom
Job Category: Medical
Work Location: 1 Longwalk Road UB11 1DB
Organization: Medical Affairs Operations
Employee Status: Full-time
Job Type: Regular

Purpose:

You will assist in the development of and conduct a variety of Medical Affairs initiatives, also providing technical/scientific consultation to both the medical and commercial team to ensure accuracy and compliance with the Celgene standard and local rules and regulations. With a high level of therapy area expertise, you will develop a network of external opinion leaders and other stakeholders in order to develop and deliver medical affairs initiatives.

Role and Responsibilities:

• Act as therapy area expert to provide strategic medical input into the company decisions on specified therapeutic areas as required
• Provide portfolio of data and medical/scientific input to HTA or other market access submissions as required
• Attends scientific congresses and meetings to maintain therapy area knowledge and to develop/maintain relationships with external customers and influential bodies on behalf of Celgene as required
• To lead on key congress activities such as Scientific Reviews or Advisory Boards
• Provide scientific input & feedback on IIT proposals
• To advise on compliance issues, review and approve materials to ensure all claims are substantiated by scientific data and are in accordance with the ABPI/IPHA Codes of Practice ( for example those materials and arrangements related to advisory boards)
• To work collaboratively within the brand team to provide strategic medical and scientific input into brand plans to develop an appropriate product strategy
• Take responsibility for and manage the execution of the medical strategic plan
• To provide leadership and support to other Medical Affairs teams (medical liaison and medical information)
• Provide support to the Director, Medical Affairs in developing and implementing Medical Affairs' initiatives to support the needs of Celgene UK & Ireland:
• Ensuring training of staff to meet technical, medical and interpersonal challenges of their roles
• Develop scientific presentations (for example those for RML use, or educational materials)
• Develop and review training documents to check medical accuracy and compliance with regulatory requirements in order to deliver training to medical and commercial colleagues on such matters as therapy area awareness, competitor data, congress updates etc.
• Provide scientific support to Marketing, Regulatory, Market Access, Pharmacovigilance and Risk Management groups
• Ensure adverse events and pregnancy reports are duly processed in line with company procedures and assist in assessment of adverse event reports originating in the UK and Ireland for completeness, consistency and reporting requirements
• Advise on medical safety or clinical issues as required

Skills and Knowledge Requirements:

• Medical or pharmacy degree
• Final medical signatory
• Prior Myeloma experience is desirable, alternatively Haematology oncology experience required
• Extensive pharmaceutical industry experience in medical affairs
• Demonstrable understanding of regulatory, pharmacovigilance and clinical development.
• Excellent verbal and written communication and organisational skills
• Strong identification with Celgene's values
• Excellent interpersonal skills
• Compliance with ABPI Code of Practice
• Sound analytical skills
• Project and time management skills
• Innovative and creative thinking

About Us

COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE

At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.

"At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients."

There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin's lymphoma (NHL), triple-negative breast cancer and pancreatic cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.